Results

Total Results: 4,100 records

Showing results for "author year description".

3501. Diagnosing Diagnosis Errors: Lessons from a Multi-institutional Collaborative Project (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Schiff.pdf
      January 01, 2005 - The authors used this approach to analyze diagnosis errors collected over a 3-year period of weekly … Illustrative disease-specific studies of diagnosis errors Author Disease/Design Findings Steere … Author affiliations Cook County John H. … diagnosis error Lessons and issues raised by the diagnosis error cases Conclusion Acknowledgments Author … None) /PDFXOutputCondition () /PDFXRegistryName (http://www.color.org) /PDFXTrapped /Unknown /Description

3502. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Update of the Evidence (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/y6xRBv7uSZY5bGCx7y48x7
      May 01, 2009 - Ann Intern Med. 2009;150:632-639. www.annals.org For author affiliations, see end of text. … Characteristics and Results of Studies Included for Key Questions 1 and 2 Study, Year (Reference) Design … Current author addresses are available at www.annals.org. References 1. … Defects www.annals.org 5 May 2009 Annals of Internal Medicine Volume 150 • Number 9 639 Current Author … Studies Excluded After Abstraction and Quality Rating for Key Question 2 (Harms) Study, Year (Reference

3503. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment_research-protocol.pdf
      December 20, 2011 - Diagnostic criteria (DSM-IV-TR) for posttraumatic stress disorder Criterion Symptom or description … The PTSD interview: rationale, description, reliability, and concurrent validity of a DSM-III-based … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description … PTSD outcome measures Outcome Measure Description Clinician-Administered PTSD Scale (CAPS)2, 28 … Source: www.effectivehealthcare.ahrq.gov Published Online: December 20, 2011 Outcome Measure Description

3504. Section 5, Figure 1 and Tables 1-5 (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-figure-1-tables-1-5.pdf
      January 01, 2011 - Prevention Program Guidelines, and patient teaching and communication → → → → 2 in preceding year … Prevention Program Guidelines, and patient teaching and communication → 3 → nc in preceding year … , High risk (<3 years old), Difficulty coordinating complex care Lewis21 English-speaking 6-17 year … 1 (but not year 2) for the overall study population i In the more complex subgroup assigned to the … Parents' roles in decision making for children with cancer in the first year of cancer treatment.

3505. Archived: Evidence Summary: Preeclampsia: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/preeclampsia-screening-april-2017
      April 25, 2017 - Further details are available from the USPSTF procedure manual. 14 Text Description . … Text Description . … Text Description .

3506. Methods-Balancing-Harms-Benefits Research-2012 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
      January 01, 2012 - The findings and conclusions in this document are those of the author(s), who are responsible for its … ............................................................................................. 18 Description … ........................................................................................ 19 Brief Description … Description of Key Characteristics of 16 Quantitative Approaches for Benefit Harm Assessment Quantitative … Brief Description of Key Characteristics of Each Approach Here we first summarize the 16 approaches

3507. Draft Comparative Effectiveness Review Appendicies (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
      April 01, 2005 - Sample Data Extraction Form Sample Data Extraction Form Author (first) Year Identifier Interventions … (Describe differences) Comments: Description of ANGIOPLASTY Intervention Description of MEDICAL … Survival following renal artery stent revascularization: four-year follow-up. … Stent placement in the renal artery: three-year experience with the Palmaz stent. … Treatment of renovascular hypertension: one year results of renal angioplasty.

3508. Electronic Exchange of Poisoning Information - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r01hs021472-cummins-final-report-2019.pdf
      January 01, 2019 - PCC, Intermountain Healthcare (IHC), and the Utah Health Information Network (UHIN) during the first year … Upon implementation and stabilization of iCentra at two study sites in year three, we were able to assess

3509. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
      March 09, 2010 - Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

3510. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
      April 01, 2016 - all lung cancers.3 Despite advances in diagnosis, treatment, and management of lung cancer, the 5-year … marrow, and brain.7 Patients with SCLC who have extensive disease at diagnosis have an estimated 5-year … Duplicates were identified by examination of author names, study centers, patient enrollment dates,

3511. Surveillance of Surgery-related Adverse Events in Missouri Using ICD-9-CM Codes (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Tuinen.pdf
      March 01, 2004 - of AEs for this study, each panelist reviewed a worksheet including a subset of the codes with a description … Author affiliations Missouri Department of Health and Senior Services (MVT, SE, CL, SL). … Abstract Introduction Methods Analysis Results Discussion Conclusions Acknowledgments Author … None) /PDFXOutputCondition () /PDFXRegistryName (http://www.color.org) /PDFXTrapped /Unknown /Description

3512. Chipra-89-Adhd-Behavior-Section-5-Attach-5 (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
      February 02, 2012 - This group met over a 2-year period, during which it reviewed the changes in practice that have occurred … review for the de- velopment of the DSM-V, but these changes will not be available until at least 1 year … The effects diminished by the third year of treatment, but no com- pensatory rebound effects were found … part of the Individuals With TABLE 1 Evidence-Based Behavioral Treatments for ADHD Intervention Type Description … medications can be effectively titrated on a 3- to 7-day basis.65 It is important to note that by the 3-year

3513. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-measure-1-section-5-attachment-5.pdf
      February 02, 2012 - This group met over a 2-year period, during which it reviewed the changes in practice that have occurred … review for the de­ velopment of the DSM-V, but these changes will not be available until at least 1 year … The effects diminished by the third year of treatment, but no com­ pensatory rebound effects were … pediatrics.aappublications.org/ TABLE 1 Evidence-Based Behavioral Treatments for ADHD Intervention Type Description … medications can be effectively titrated on a 3- to 7-day basis.65 It is important to note that by the 3-year

3514. final Fibromyalgia CER protocol_3-31-14 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research-protocol.pdf
      April 03, 2014 - These fields will include author, year of publication; setting, subject inclusion and exclusion criteria … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description … Treatments for Fibromyalgia in Adult Subgroups Risk of Bias Assessment for Observational Studies Author … Year PMID Reviewer Question Response Criteria Justification Internal Validity 1.

3515. A Guide to Real-World Evaluations of Primary Care Interventions: Some Practical Advice (pdf file)
      www.ahrq.gov/sites/default/files/publications2/files/guide-to-real-world-evaluations.pdf
      October 01, 2014 - the intervention was ineffective or the evaluation had low statistical power (see Appendix A for a description … As an example of this process, consider a description of the pathway linking implementation to outcomes … For example, if they begin 1 year later than the early starters, your evaluation will have only 1 year … as comparing practices with 2 years of experience with the intervention and practices with only 1 year

3516. Disposition of Comments Report for Medication Adherence Interventions: Comparative Effectiveness (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_disposition-comments.pdf
      September 11, 2012 - We added some text explaining our preference for long outcomes at 1 year or greater Peer Reviewer

3517. Surveys on Patient Safety Culture (SOPS) Medical Office Survey: 2020 User Database Report Part I (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2020_MOSOPS_Part_I-rev0921.pdf
      January 01, 2020 - for Users of the AHRQ Medical Office Survey ........................................... 39 Notes: Description … 18,396 Tenure in Medical Office Number Percent Less than 2 months 450 3% 2 months to less than 1 year … 2,653 17% 1 year to less than 3 years 4,290 27% 3 years to less than 6 years 3,568 22% 6 years … wysiwyg/sops/surveys/medoffice-resourcelist.pdf 2020 SOPS Medical Office Database Report 40 Notes: Description … Improvement AHRQ Action Planning Tool Resource List for Users of the AHRQ Medical Office Survey Notes: Description

3518. Appendix K Rapid Evidence Review Treatments for Clostridium difficile Colitis (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
      February 01, 2018 - Exclude prevention and therapies not likely to be available on U.S. market within 1 year. … transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: Description

3519. Diagnostic error in mental health: a review (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/topics/dx-safety-mental-health-bmjqs.pdf
      April 15, 2024 - Houston, Texas, USA; Andrea.Bradford@bcm.edu Received 4 December 2023 Accepted 4 March 2024 © Author … BMJ Qual Saf Epub ahead of print: [please include Day Month Year]. doi:10.1136/ bmjqs-2023-016996 … Recommendations for future Type of diagnostic error Description of approach Example of use of this approach … In addition, the author Ashley N D Meyer was incorrectly listed as Ashley Mayer. … Characterizing health disparities in the age of autism diagnosis in a study of 8-year-old children.

3520. Ambulatory Safety Nets to Reduce Missed and Delayed Diagnoses of Cancer | PSNet
      psnet.ahrq.gov/innovation/ambulatory-safety-nets-reduce-missed-and-delayed-diagnoses-cancer
      February 26, 2025 - Description of the Innovative Activity An ASN is a collection of tools, reports, registries, and workflows … success of the ASN has instilled a culture of innovation within the local hospital system upon which the author